Short-Term Safety and Effectivess of Apipuncture in Knee Osteoarthritis: A Single-Arm Clinical Trial
Article Sidebar
Main Article Content
Abstract
Objective: Osteoarthritis, a degenerative joint disease, often poses challenges in conventional medical treatment, leading patients to explore traditional and complementary medicine options including apitherapy. Bee venom, known for its analgesic and anti-inflammatory properties, has been considered as a potential therapy. This study investigates the short-term safety and effectiveness of applying live bee venom in knee osteoarthritis patients.
Materials and Methods: Conducted at a university hospital's Apitherapy Clinic, this single-arm clinical trial enrolled individuals diagnosed with mild to moderate knee osteoarthritis (stage 2-3). A single session of live bee venom application was administered to acupuncture points ST35, EX-LE4, and ash-chi, specifically targeting the painful knee joint. Data collection involved the utilization of a Demographic Information Questionnaire and SF-12 Scale, along with a comparison of the Numerical Rating Scale (NRS), 5 Times Sit-to-Stand Test (5xSST), and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire before and after the treatment.
Results: Before the treatment, the average NRS value stood at 7.14 ± 1.7, and following the intervention, it notably decreased to 3.06 ± 2.16 (p<0.05). Additionally, the mean value for the 5xSST decreased from 14.59 ± 3.36 before treatment to 11.75 ± 2.30 after treatment. The WOMAC scale also showed a significant difference between pre- and post-treatment (p<0.05), with the mean value decreasing from 41.91 ± 18.07 before treatment to 15.57 ± 15.14 after treatment.
Conclusion: The findings of this study indicate a significant improvement in the NRS, 5xSST, and WOMAC scales after the administration of live bee venom for knee osteoarthritis patients.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2023-08-05
Published 2023-08-13
References
Katz JN, Arant KR, Loeser RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. JAMA. 2021;325(6):568–78.
Strohmaier H, Spruck CH, Kaiser P, Won KA, Strohmaier H, Reed SI. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci. 2002;59(1):45–53.
Cesare PE, Abramson SB. Osteoartrit Patogenezi. In: Dinçer F, editor. Kelley Romatology. Güneş Kitabevi; 2006. p. 1493–513.
Rodriguez-Veiga D, González-Martín C, Pertega-Díaz S, Seoane-Pillado T, Barreiro-Quintás M, Balboa-Barreiro V. Prevalence of osteoarthritis of the knee in a random population sample of people aged 40 and older. Gac Med Mex. 2019;155(1):37–43.
Garstang S V, Stitik TP. Osteoarthritis: epidemiology, risk factors, and pathophysiology. Am J Phys Med Rehabil. 2006;85(11 Suppl).
Nguyen USDT, Zhang Y, Zhu Y, Niu J, Zhang B, Felson DT. Increasing prevalence of knee pain and symptomatic knee osteoarthritis: Survey and cohort data. Ann Intern Med. 2011;155(11):725–32.
Øiestad BE, Juhl CB, Eitzen I, Thorlund JB. Knee extensor muscle weakness is a risk factor for development of knee osteoarthritis. A systematic review and meta-analysis. Osteoarthritis Cartilage. 2015;23(2):171–7.
Hooper MM, Holderbaum D, Moskowitz RW. Clinical and laboratory findings in osteoarthritis. In: Koopman WJ, Moreland LW, editors. Arthritis and allied conditions A textbook of Rheumatology. 15th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 2227–55.
Leslie M. Knee osteoarthritis management therapies. Pain Manag Nurs. 2000;1(2):51–7.
Lee LS, Chan PK, Fung WC, Chan VWK, Yan CH, Chiu KY. Imaging of knee osteoarthritis: A review of current evidence and clinical guidelines. Musculoskeletal Care. 2021;19(3):363–74.
Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020;72(2):149–62.
Kikuchi M, Matsuura K, Matsumoto Y, Inagaki T, Ueda R. Bibliographical investigation of complementary alternative medicines for osteoarthritis and rheumatoid arthritis. Geriatr Gerontol Int. 2009;9(1):29–40.
Hye JP, Seong HL, Dong JS, Ki WO, Ki HK, Ho SS, et al. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum. 2004;50(11):3504–15.
Lee G, Bae H. Anti-Inflammatory Applications of Melittin, a Major Component of Bee Venom: Detailed Mechanism of Action and Adverse Effects. 2016;21(5):616.
Kim W, Kim MJ, Go D, Min B Il, Na HS, Kim SK. Combined Effects of Bee Venom Acupuncture and Morphine on Oxaliplatin-Induced Neuropathic Pain in Mice. Toxins. 2016;8(2):33.
Aufschnaiter A, Kohler V, Khalifa S, El-Wahed AA, Du M, El-Seedi H, et al. Apitoxin and Its Components against Cancer, Neurodegeneration and Rheumatoid Arthritis: Limitations and Possibilities. Toxins. 2020;12(2):66.
Yoo J, Lee G. Adverse Events Associated with the Clinical Use of Bee Venom: A Review. Toxins. 2022;14(8):562.
Bordon K de CF, Cologna CT, Fornari-Baldo EC, Pinheiro-Júnior EL, Cerni FA, Amorim FG, et al. From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery. Front Pharmacol. 2020;11:553397.
Wehbe R, Frangieh J, Rima M, Obeid D El, Sabatier JM, Fajloun Z. Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests. Molecules. 2019;24(16):2997.
Zhu F, Wongsiri S. A Brief Introduction to Apitherapy Health Care. Journal of Thai Traditional and Alternative Medicine. 2008;6(3):303–12.
T. C. Sağlık Bakanlığı. Geleneksel ve Tamamlayıcı Tıp Uygulamaları Yönetmeliği. 29158 Oct 27, 2014. Available from: https://www.resmigazete.gov.tr/eskiler/2014/10/20141027-3.htm
Taechaarpornkul W, Suvapan D, Theppanom C, Chanthipwaree C, Chirawatkul A. Comparison of the effectiveness of six and two acupuncture point regimens in osteoarthritis of the knee: a randomised trial. Acupuncture in medicine : journal of the British Medical Acupuncture Society. 2009;27(1):3–8.
Soylu C, Kütük B. Reliability and Validity of the Turkish Version of SF-12 Health Survey. Turk Psikiyatri Derg. 2022;33(2):108–17.
Nugent SM, Lovejoy TI, Shull S, Dobscha SK, Morasco BJ. Associations of Pain Numeric Rating Scale Scores Collected during Usual Care with Research Administered Patient Reported Pain Outcomes. Pain Medicine. 2021;22(10):2235–41.
Bellamy N. WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire. J Rheumatol. 2002;29(12).
Bellamy N, Buchanan W, Goldsmith C, Campbell J, Stitt L. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988
Tüzün EH, Eker L, Aytar A, Daşkapan A, Bayramoǧlu M. Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthritis Cartilage. 2005;13(1):28–33.
Mong Y, Teo TW, Ng SS. 5-Repetition Sit-to-Stand Test in Subjects With Chronic Stroke: Reliability and Validity. Arch Phys Med Rehabil. 2010;91(3):407–13.
Lee YJ, Jo HR, Kim SH, Sung WS, Kim EJ, Lee YJ, et al. Efficacy and Safety of Pharmacopuncture and Bee venom Acupuncture for Knee Osteoarthritis: A systematic review and meta-analysis. Journal of Korean Medicine. 2020;41(1):55–83.
Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms Underlying Inflammation in Neurodegeneration. Cell. 2010;140(6):918–34.
Lee SM, Yang EJ, Choi SM, Kim SH, Baek MG, Jiang JH. Effects of bee venom on glutamate-induced toxicity in neuronal and glial cells. Evidence-based Complementary and Alternative Medicine. 2012;2012.
Bigagli E, Luceri C, Bernardini S, Dei A, Filippini A, Dolara P. Exploring the effects of homeopathic Apis mellifica preparations on human gene expression profiles. Homeopathy. 2014;103(2):127–32.
Moon DO, Park SY, Lee KJ, Heo MS, Kim KC, Kim MO, et al. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol. 2007;7(8):1092–101.
Saeed W, Saeed E, Awad E, Khalil G. Immune Response Modifying Effects of Bee Venom Protein [Melittin]/Autoclaved L. donovani complex in CD1 Mice: The Search for New Vaccine Adjuvants. J Vaccines Vaccin. 2017;8(6):1–6.
Chen J, Lariviere WR. The nociceptive and anti-nociceptive effects of bee venom injection and therapy: A double-edged sword. Prog Neurobiol. 2010;92(2):151–83.
Khalil A, Elesawy BH, Ali TM, Ahmed OM. Bee Venom: From Venom to Drug. Molecules. 2021;26(16):4941.
Kwon YB, Lee HJ, Han HJ, Mar WC, Kang SK, Yoon OB, et al. The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci. 2002;71(2):191–204.
Pyo MC, Choi IG, Lee KW. Transcriptome Analysis Reveals the AhR, Smad2/3, and HIF-1α Pathways as the Mechanism of Ochratoxin A Toxicity in Kidney Cells. Toxins. 2021;13(3):190.